Legence (LGN) Insider Grants 8,036 RSUs to Bryce Seki, Vesting Over 3 Years
Rhea-AI Filing Summary
Legence Corp. insider reported an award of 8,036 Restricted Stock Units (RSUs) on 09/15/2025 to Bryce Seki, General Counsel & Secretary. Each RSU converts to one share of Class A common stock at vesting and carries no purchase price. The RSUs vest in three substantially equal installments on each of the first, second and third anniversaries of the award date, subject generally to continued employment through each vesting date. Following the grant, the reporting person beneficially owns 8,036 shares of Class A common stock.
Positive
- Grant of 8,036 RSUs to a senior officer aligns executive incentives with shareholder value
- Three-year vesting spreads retention incentive and potential dilution over multiple years
Negative
- No material negative items disclosed in this Form 4; filing reports a routine equity award
Insights
TL;DR: Routine equity compensation awarded to a senior officer; standard time-based vesting, not immediately dilutive beyond future vesting.
The Form 4 discloses a time-based grant of 8,036 RSUs to the company's General Counsel & Secretary. The award vests over three years in substantially equal installments, aligning executive retention incentives with service rather than immediate transfer of shares. The filing reports a beneficial ownership position of 8,036 Class A shares post-grant. There is no exercise price and no accelerated vesting or derivative transactions disclosed. From a governance perspective, this appears to be a standard compensation action without disclosed performance conditions or material deviations from common equity award terms.
TL;DR: Compensation grant is routine and time-based; impact on outstanding shares depends on future vesting and settlement mechanics.
The report indicates the grant is denominated as RSUs convertible one-for-one into Class A common stock at vesting and that the recipient beneficially owns 8,036 shares after the award. The vesting schedule—three substantially equal annual installments—spreads potential dilution across three years. The Form 4 does not disclose cash settlement, tax withholding method, or whether shares will be net-settled, so the exact future share issuance timeline and dilution magnitude cannot be determined from this filing alone.